ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Evaluation of Rejection, Infection, and Malignancy Outcomes in Elderly Liver Transplant Recipients Compared to a Younger Cohort

B. Almalki1, K. Cunningham1, C. D'Agostino1, M. Kapugi1, C. Kane1, A. Novak1, D. Ladner2, J. Schulte1

1Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL, 2Division of Transplant Surgery, Northwestern Memorial Hospital, Chicago, IL

Meeting: 2020 American Transplant Congress

Abstract number: A-134

Keywords: Immunosuppression

Session Information

Session Name: Poster Session A: Liver: Immunosuppression and Rejection

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Previous data has shown elderly liver transplant recipients (LTx) to be at a lower risk of acute rejection than younger recipients. As such, elderly recipients may benefit from reduced immunosuppression (IS) exposure to minimize infectious and malignant complications without a corresponding impact on rejection. The objective of this analysis is to evaluate outcomes in LTx recipients 60 years and older compared to a younger cohort 18 – 59 years maintained on a similar level of IS.

*Methods: This was a single-center retrospective evaluation of adult LTx recipients from 2015-2018 who received methylprednisolone induction and were maintained on tacrolimus, mycophenolate mofetil (MMF), and a prednisone taper. Patients with multi-organ transplant, history of prior LTx, HIV, autoimmune liver disease as indication for LTx, or use of alternative IS were excluded. First episode of empiric or biopsy proven acute rejection within 1 year post-LTx was evaluated, as well as the incidence of death, infection, and malignancy.

*Results: A total of 107 LTx recipients were evaluated. Mean age in the older cohort was 65 ± 3.8 compared to 52 ± 8.3 years in the younger group (p&lt0.01). The majority of LTx were from DBD donors (68.2%). Mean tacrolimus levels at various time points and the duration of MMF and steroids were similar between groups. Incidence of first rejection within 1 year was similar between groups (21.3% vs. 21.7%, p=0.14), with no difference in patient survival, infection, or malignancy.

*Conclusions: In LTx recipients maintained on tacrolimus, MMF, and steroids, no difference in first episode of rejection within 1 year was observed in patients 60 years and older compared to a younger cohort 18 – 59 years. Rates of survival, infection, and malignancy were similar. Evaluation of additional patients may provide further insight into the study outcomes.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Almalki B, Cunningham K, D'Agostino C, Kapugi M, Kane C, Novak A, Ladner D, Schulte J. Evaluation of Rejection, Infection, and Malignancy Outcomes in Elderly Liver Transplant Recipients Compared to a Younger Cohort [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/evaluation-of-rejection-infection-and-malignancy-outcomes-in-elderly-liver-transplant-recipients-compared-to-a-younger-cohort/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences